The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis

BACKGROUND: Circulating tumor DNA (ctDNA) has been investigated as a potential prognostic biomarker to evaluate the therapeutic efficacy and disease progression in melanoma patients, yet results remain inconclusive. The purpose of this study was to illustrate the prognostic value of ctDNA in melanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, S.N., Cen, X.T., Tan, R., Wei, S.S., Sun, L.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985561/
https://www.ncbi.nlm.nih.gov/pubmed/33744725
http://dx.doi.org/10.1016/j.tranon.2021.101072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985561/
https://www.ncbi.nlm.nih.gov/pubmed/33744725
http://dx.doi.org/10.1016/j.tranon.2021.101072

Ejemplares similares